197 related articles for article (PubMed ID: 20339947)
1. Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer.
Xu CY; Guo JL; Jiang ZN; Xie SD; Shen JG; Shen JY; Wang LB
Ann Surg Oncol; 2010 Sep; 17(9):2503-9. PubMed ID: 20339947
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor subtypes in ovarian cancer: a clinical correlation.
Chan KK; Wei N; Liu SS; Xiao-Yun L; Cheung AN; Ngan HY
Obstet Gynecol; 2008 Jan; 111(1):144-51. PubMed ID: 18165403
[TBL] [Abstract][Full Text] [Related]
4. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
7. [Association between the expression of estrogen receptor subunit in endometrial carcinoma and the prognostic factors of endometrial carcinoma].
Zhang JW; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):843-5. PubMed ID: 15573770
[TBL] [Abstract][Full Text] [Related]
8. Loss of estrogen receptor beta expression at cancer front correlates with tumor progression and poor prognosis of gallbladder cancer.
Sumi K; Matsuyama S; Kitajima Y; Miyazaki K
Oncol Rep; 2004 Nov; 12(5):979-84. PubMed ID: 15492781
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta variants mRNA expressions in gastric cancer tissues and association with clinicopathologic parameters.
Guo JL; Xu CY; Jiang ZN; Dong MJ; Xie SD; Shen JG; Cao J; Wang LB
Hepatogastroenterology; 2010; 57(104):1584-8. PubMed ID: 21443125
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of protein kinase Calpha mRNA may be an independent prognostic marker for gastric carcinoma.
Lin KY; Fang CL; Uen YH; Chang CC; Lou HY; Hsieh CR; Tiong C; Pan S; Chen SH
J Surg Oncol; 2008 May; 97(6):538-43. PubMed ID: 18314869
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis.
Wang JD; Dong YC; Sheng Z; Ma HH; Li GL; Wang XL; Lu GM; Sugimura H; Jin J; Zhou XJ
Oncology; 2007; 73(3-4):238-45. PubMed ID: 18424888
[TBL] [Abstract][Full Text] [Related]
12. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
[TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell-Thompson M; Lynch IJ; Bhardwaj B
Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
[TBL] [Abstract][Full Text] [Related]
16. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W
J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283
[TBL] [Abstract][Full Text] [Related]
18. The ratio of estrogen receptor alpha to estrogen receptor beta in adipose tissue is associated with leptin production and obesity.
Shin JH; Hur JY; Seo HS; Jeong YA; Lee JK; Oh MJ; Kim T; Saw HS; Kim SH
Steroids; 2007 Jun; 72(6-7):592-9. PubMed ID: 17509633
[TBL] [Abstract][Full Text] [Related]
19. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
[TBL] [Abstract][Full Text] [Related]
20. CpG methylation of the ERalpha and ERbeta genes in breast cancer.
Kim SJ; Kim TW; Lee SY; Park SJ; Kim HS; Chung KW; Lee ES; Kang HS
Int J Mol Med; 2004 Aug; 14(2):289-93. PubMed ID: 15254780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
